Anti-SARS CoV-2 Spike Glycoprotein South Africa variant-South Africa variant antibody (400-450) {FITC} (STJ506305)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationFITC
IsotypeIgG
ImmunogenSynthetic peptide corresponding to amino acids within region 400-450 on SARS CoV-2 Spike Glycoprotein South Africa varian.
General Information
| Short Description | Rabbit polyclonal antibody anti-SARS CoV-2 Spike Glycoprotein South Africa variant-South Africa variant (400-450) is suitable for use in ELISA, Immunoprecipitation and Western Blot research applications. |
| Applications | ELISA/IP/WB |
| Host | Rabbit |
| Reactivity | SARS-CoV-2 |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | FITC |
| Concentration | 0.5-1.5 Mu g/Mu l |
| Purification | Affinity Purified |
| Dilution Range | ELISA 1:10, 000ICC 1:50-1:100IF 1:50-1:100IHC 1:50-1:100IP 1:200WB 1:500 |
| Formulation | Contains Tris, HCl/Glycine buffer pH 7.4-7.8, 30% Glycerol and 0.5% BSA, along with cryo-protective agents, Hepes, and long-term preservatives (0.02% Sodium Azide). |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide corresponding to amino acids within region 400-450 on SARS CoV-2 Spike Glycoprotein South Africa varian. |
| Immunogen Region | 400-450 |